Medtronic plc
Deutsche BörseTotal Valuation
Medtronic plc carries a market capitalization of 85.28B, placing it among publicly traded companies globally. Its enterprise value stands at 149.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 85.28B |
| Enterprise Value | 149.70B |
Share Statistics
Medtronic plc currently has 1.28B shares outstanding.
| Shares Outstanding | 1.28B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Medtronic plc trades at a trailing price-to-earnings ratio of 28.14. The price-to-sales ratio is 3.66, and the price-to-book ratio stands at 4.02.
| PE Ratio | 28.14 |
| PS Ratio | 3.66 |
| PB Ratio | 4.02 |
| P/TBV Ratio | -42.82 |
| P/FCF Ratio | 14.24 |
| P/OCF Ratio | 17.82 |
Enterprise Valuation
On an enterprise value basis, Medtronic plc trades at an EV/EBITDA multiple of 15.44 and an EV/FCF ratio of 15.35. The EV/Sales ratio of 4.22 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 22.64 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.22 |
| EV / EBITDA | 15.44 |
| EV / EBIT | 22.64 |
| EV / FCF | 15.35 |
Financial Position
Medtronic plc maintains a current ratio of 2.54, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 57.06, indicating elevated leverage, while an interest coverage ratio of 13.61 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.54 |
| Quick Ratio | 1.55 |
| Debt / Equity | 57.06 |
| Debt / EBITDA | 2.90 |
| Interest Coverage | 13.61 |
Financial Efficiency
Medtronic plc posts a return on equity of 14.50 and a return on invested capital of 7.12.
| Return on Equity (ROE) | 14.50 |
| Return on Assets (ROA) | 5.08 |
| Return on Invested Capital (ROIC) | 7.12 |
| Return on Capital Employed (ROCE) | 8.73 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.09 |
Taxes
Over the trailing twelve months, Medtronic plc has paid 923.00M in income taxes, reflecting an effective tax rate of 16.59.
| Income Tax | 923.00M |
| Effective Tax Rate | 16.59 |
Stock Price Statistics
Medtronic plc's stock has declined approximately -11.39274% over the past 52 weeks. The 50-day moving average sits at 69.97, while the 200-day moving average is 79.42.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.39274% |
| 50-Day Moving Average | 69.97 |
| 200-Day Moving Average | 79.42 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Medtronic plc generated 35.48B in revenue and converted that into 4.61B in net income, yielding earnings per share of 3.60. EBITDA reached 9.69B, while operating income came in at 6.61B.
| Revenue | 35.48B |
| Gross Profit | 23.01B |
| Operating Income | 6.61B |
| Pretax Income | 5.56B |
| Net Income | 4.61B |
| EBITDA | 9.69B |
| EBIT | 6.61B |
| Earnings Per Share (EPS) | 3.60 |
Balance Sheet
Medtronic plc holds 8.38B in cash and equivalents against 28.07B in total debt, resulting in a net debt position of 26.87B. Total book value stands at 32.30B, with working capital of 14.58B providing operational flexibility.
| Cash & Cash Equivalents | 8.38B |
| Total Debt | 28.07B |
| Net Debt | 26.87B |
| Equity (Book Value) | 32.30B |
| Book Value Per Share | 25.19 |
| Working Capital | 14.58B |
Cash Flow
Medtronic plc produced 7.29B in operating cash flow over the past twelve months. After subtracting -1.87B in capital expenditures, free cash flow totaled 5.41B - equivalent to 4.22 per share.
| Operating Cash Flow | 7.29B |
| Capital Expenditures | -1.87B |
| Free Cash Flow | 5.41B |
| FCF Per Share | 4.22 |
Margins
Medtronic plc operates with a gross margin of 64.86, reflecting its pricing power and cost economics. The operating margin of 18.63 and net profit margin of 13.00 provide insight into operational efficiency.
| Gross Margin | 64.86 |
| Operating Margin | 18.63 |
| Pretax Margin | 15.68 |
| Profit Margin | 13.00 |
| EBITDA Margin | 27.32 |
Dividends & Yields
The company's payout ratio of 77.79 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 2.83 |
| Dividend Yield | N/A |
| Payout Ratio | 77.79 |
| Shareholder Yield | 4.01 |
| FCF Yield | 7.02 |
Scores
Medtronic plc posts an Altman Z-Score of 4.90, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.90 |